Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Vivendi (VIV.PA)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (€) Price Target (€) Rating
2022-03-3011.9016.00Buy
2022-07-199.8615.50Buy
2022-07-289.9815.10Buy
2022-10-217.8814.40Buy
2023-01-269.7914.60Buy
2023-03-089.8615.40Buy
2023-05-239.1015.10Buy
2023-06-298.4015.00Buy
2023-10-038.4114.70Buy
2024-01-2610.2115.20Buy
2024-03-139.7915.50Buy
2024-07-299.9712.50Buy
2024-09-1310.0912.70Buy
2024-10-2210.4313.10Buy
2024-11-119.2511.00Buy
2024-11-198.7510.00Buy
2024-12-172.513.00Buy
2025-03-112.783.25Buy
2025-04-092.302.80Buy
2025-04-282.593.20Buy

Disclosures

  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.